Skip to main content
Samuel Agresta, MD, Oncology, Tampa, FL

Samuel Agresta MD MPH TM


Vice President, Agios Clinical Development

Join to View Full Profile
  • 12902 Usf Magnolia DrTampa, FL 33612

  • Phone+1 813-745-5768

Dr. Agresta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
    University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Tulane University
    Tulane UniversityResidency, Internal Medicine, 1999 - 2003
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2006 - 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Therapeutics Expands Leadership Team with Two C-suite Appointments
    Therapeutics Expands Leadership Team with Two C-suite AppointmentsSeptember 16th, 2019
  • Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of Directors
    Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of DirectorsAugust 22nd, 2019
  • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Ratings Summary as of Dec 18, 2018
    Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Ratings Summary as of Dec 18, 2018December 18th, 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: